Stock PCVX VAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Real-time Estimate Cboe BZX
Other stock markets
 19:59:42 02/05/2024 BST 		5-day change 1st Jan Change
64.78 USD +1.67% Intraday chart for Vaxcyte, Inc. +7.64% +2.95%
04-25 Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing MT
04-22 Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing
MT
Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing
MT
Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating
MT
Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating
MT
Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69
MT
TD Cowen Starts Vaxcyte at Outperform
MT
BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating
MT
Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating
MT
Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating
MT
SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60
MT
Guggenheim Initiates Vaxcyte at Buy With $66 Price Target
MT
BTIG Starts Vaxcyte at Buy With $69 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PCVX Stock
  4. News Vaxcyte, Inc.
  5. Analyst Reco.